Total Payments
$227,043
2024 Payments
$21,746
Companies
6
Transactions
247
Medicare Patients
365
Medicare Billing
$47,805
Payment Breakdown by Category
Consulting$186,309 (82.1%)
Travel$31,973 (14.1%)
Food & Beverage$4,263 (1.9%)
Other$4,227 (1.9%)
Royalty/License$262.00 (0.1%)
Education$7.58 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $186,309 | 62 | 82.1% |
| Travel and Lodging | $31,973 | 84 | 14.1% |
| Food and Beverage | $4,263 | 96 | 1.9% |
| Grant | $4,227 | 3 | 1.9% |
| Royalty or License | $262.00 | 1 | 0.1% |
| Education | $7.58 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $93,621 | 104 | $0 (2023) |
| ViiV Healthcare Company | $63,401 | 60 | $0 (2024) |
| Gilead Sciences, Inc. | $49,535 | 56 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $13,810 | 23 | $0 (2022) |
| GlaxoSmithKline, LLC. | $5,025 | 3 | $0 (2022) |
| ABBVIE INC. | $1,650 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21,746 | 17 | ViiV Healthcare Company ($12,373) |
| 2023 | $26,965 | 28 | Merck Sharp & Dohme LLC ($14,885) |
| 2022 | $26,643 | 20 | Merck Sharp & Dohme LLC ($10,634) |
| 2021 | $16,050 | 8 | ViiV Healthcare Company ($6,440) |
| 2020 | $19,235 | 18 | ViiV Healthcare Company ($8,665) |
| 2019 | $56,416 | 68 | Merck Sharp & Dohme Corporation ($35,497) |
| 2018 | $19,321 | 24 | Gilead Sciences, Inc. ($9,730) |
| 2017 | $40,667 | 64 | Merck Sharp & Dohme Corporation ($19,331) |
All Payment Transactions
247 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| 09/09/2024 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $3,848.78 | General |
| 07/25/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $73.95 | General |
| 07/02/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| 04/15/2024 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $4,550.00 | General |
| 03/15/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $60.00 | General |
| 03/15/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $46.19 | General |
| 03/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.03 | General |
| 03/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.54 | General |
| 03/15/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $15.85 | General |
| 03/15/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $15.85 | General |
| 03/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.06 | General |
| 03/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.40 | General |
| 02/14/2024 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,950.00 | General |
| 02/02/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $622.98 | General |
| 02/02/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $275.76 | General |
| 01/31/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $656.85 | General |
| 11/20/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $6,045.00 | General |
| 11/20/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 11/10/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $263.44 | General |
| 11/10/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $92.44 | General |
| 11/10/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $67.74 | General |
| 11/10/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $59.24 | General |
| 11/10/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $47.42 | General |
| 11/10/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $25.29 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 68 | 97 | $29,422 | $8,210 |
| 2022 | 6 | 120 | 218 | $64,032 | $17,666 |
| 2021 | 4 | 89 | 138 | $37,637 | $10,143 |
| 2020 | 4 | 88 | 172 | $44,405 | $11,786 |
Total Patients
365
Total Services
625
Medicare Billing
$47,805
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 23 | $8,937 | $2,582 | 28.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 27 | $8,379 | $2,442 | 29.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $6,868 | $1,582 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 18 | $5,000 | $1,461 | 29.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 17 | $238.00 | $142.80 | 60.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 99 | $29,898 | $7,586 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 32 | $12,416 | $4,434 | 35.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $9,134 | $2,425 | 26.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 34 | $7,140 | $1,872 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 19 | $5,282 | $1,296 | 24.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 18 | $162.00 | $53.13 | 32.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 29 | 56 | $11,955 | $3,128 | 26.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 33 | $8,868 | $2,832 | 31.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 23 | 36 | $10,970 | $2,809 | 25.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 13 | 13 | $5,844 | $1,373 | 23.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 38 | 114 | $24,510 | $6,414 | 26.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 34 | $8,860 | $2,463 | 27.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 11 | $6,522 | $1,658 | 25.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 12 | 13 | $4,513 | $1,251 | 27.7% |
About Dr. Joseph Eron, MD
Dr. Joseph Eron, MD is a Infectious Disease healthcare provider based in Chapel Hill, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598838336.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Eron, MD has received a total of $227,043 in payments from pharmaceutical and medical device companies, with $21,746 received in 2024. These payments were reported across 247 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($186,309).
As a Medicare-enrolled provider, Eron has provided services to 365 Medicare beneficiaries, totaling 625 services with total Medicare billing of $47,805. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Chapel Hill, NC
- Active Since 11/17/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1598838336
Products in Payments
- DELSTRIGO (Drug) $12,625
- DOVATO (Drug) $6,930
- MK-8591A (Drug) $5,075
- PREZISTA (Drug) $4,979
- CABENUVA (Drug) $4,950
- EDURANT (Drug) $4,341
- Biktarvy (Drug) $2,935
- CABENUVA (Biological) $2,760
- MK-4482 (Biological) $1,700
- MK-8591 (Drug) $1,401
- ISENTRESS (Drug) $750.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Chapel Hill
David Wohl, M.d, M.D
Infectious Disease — Payments: $941,907
Infectious Disease $941,907
Dr. David Van Duin, M.d, M.D
Infectious Disease — Payments: $85,138
Infectious Disease $85,138
Dr. Myron Cohen, Md, MD
Infectious Disease — Payments: $59,254
Infectious Disease $59,254
Dr. David Margolis, Md, MD
Infectious Disease — Payments: $44,821
Infectious Disease $44,821
Dr. Michelle Floris-Moore, Md, MD
Infectious Disease — Payments: $26,360
Infectious Disease $26,360
Dr. Becky White, Md, MD
Infectious Disease — Payments: $16,737
Infectious Disease $16,737